Name | BIOLINK, OOO |
|---|
INN | 5408174940 |
|---|
KPP | 540801001 |
|---|
OGRN | 1025403643913 |
|---|
OKPO | 57201404 |
|---|
Address | 630090, Novosibirskaya Oblast', g. Novosibirsk, ul. Nikolaeva, d. D. 13, of. OFIS 205 |
|---|
Phone | +7 (383) 335-98-36 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 21.20.2 | Additional activity | Production of materials used in medical applications | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | All types of activities | | 46.90 | Additional activity | Nonspecialised wholesale trade | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 86 | Additional activity | Health service | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 04.10.2002 |
|---|
Registering department | Novosibirskaya gorodskaya registratsionnaya palata |
|---|
|
BIOLINK, OOO (Novosibirsk Oblast; INN 5408174940) was registered on 4 Oct 2002. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of BIOLINK, OOO - Limited liability companies. Form of ownership of BIOLINK, OOO - Private property. Principal activities of BIOLINK, OOO: research and experimental development on natural sciences and engineering other (72.19), production of materials used in medical applications (21.20.2), wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of BIOLINK, OOO dropped in 2023 3.57 times to 8.28 million RUB from 29.55 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 9.42% to 116.42 million RUB from 128.53 million RUB in 2022; cost of goods sold decreased by 14.73% to 59.49 million RUB from 69.77 million RUB; sales loss made up 4.22 million RUB compared to sales profit of 10.84 million RUB. 2022
Net profit (RAS) of BIOLINK, OOO grew over 2022 by 14.80% to 29.55 million RUB from 25.74 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 8.88% to 128.53 million RUB from 141.06 million RUB in 2021; cost of goods sold remained at the same level amounting to 69.77 million RUB compared to 70.00 million RUB; sales profit fell 3.13 times to 10.84 million RUB from 33.90 million RUB. 2021
Net profit (RAS) of BIOLINK, OOO dropped in 2021 2.13 times to 25.74 million RUB from 54.93 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 9.56% to 141.06 million RUB from 128.75 million RUB over 2020; cost of goods sold decreased by 16.38% to 70.00 million RUB from 83.71 million RUB; sales profit fell by 24.73% to 33.90 million RUB from 45.04 million RUB. 2020
Net profit (RAS) of BIOLINK, OOO grew over 2020 58.75 times to 54.93 million RUB from 935.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period 1.89 times to 128.75 million RUB from 68.14 million RUB over 2019; cost of goods sold grew by 39.00% to 83.71 million RUB from 60.22 million RUB; sales profit went up 5.69 times to 45.04 million RUB from 7.92 million RUB. 2018
Net loss (RA) of BIOLINK, OOO made up 1.09 million RUB over 2018 compared to net profit of 3.26 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 22.99% to 46.07 million RUB from 59.82 million RUB in 2017; cost of goods sold decreased by 28.90% to 40.58 million RUB from 57.07 million RUB; sales profit went up 1.99 times to 5.49 million RUB from 2.76 million RUB. 2017
Net profit (RAS) of BIOLINK, OOO grew over 2017 by 38.63% to 3.26 million RUB from 2.35 million RUB over 2016, the company informed. Revenue increased in the accounting period by 45.06% to 59.82 million RUB from 41.24 million RUB over 2016; cost of goods sold grew 1.53 times to 57.07 million RUB from 37.22 million RUB; sales profit fell by 31.42% to 2.76 million RUB from 4.02 million RUB. 2016
Net profit (RAS) of BIOLINK, OOO grew over 2016 by 31.67% to 2.35 million RUB from 1.79 million RUB over 2015, the company informed. Revenue increased in the accounting period 1.61 times to 41.24 million RUB from 25.67 million RUB over 2015; cost of goods sold grew 1.51 times to 37.22 million RUB from 24.69 million RUB; sales profit went up 4.09 times to 4.02 million RUB from 981.00 thousand RUB. 2014
Net profit (RAS) of BioLink, OOO grew over 2014 3.01 times to 3.91 million RUB from 1.30 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 1.15% to 23.04 million RUB from 23.31 million RUB in 2013; cost of goods sold grew by 15.11% to 25.59 million RUB from 22.23 million RUB; sales loss made up 2.55 million RUB compared to sales profit of 1.08 million RUB. 2013
Net profit (RAS) of BioLink, OOO grew over 2013 14.29 times to 1.30 million RUB from 91.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 24.04% to 23.31 million RUB from 18.79 million RUB over 2012; cost of goods sold grew by 20.64% to 22.23 million RUB from 18.42 million RUB; sales profit went up 2.95 times to 1.08 million RUB from 367.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|